Capping actin protein of muscle Z-line alpha subunit 1 pseudogene 3 (CAPZA1P3)

CAPZA1 pseudogene 3 is a pseudogene—a segment of genomic DNA that closely resembles the sequence of a protein-coding gene (in this case, the gene for capping actin protein of muscle Z-line alpha subunit 1, or CAPZA1)—but is rendered non-functional as a protein-coding gene due to sequence disablements such as frameshifts or premature stop codons[1][3]. Pseudogenes typically do not produce functional proteins and are not considered therapeutic targets, receptors, enzymes, or druggable proteins[1][3][5]. While some pseudogenes can possess regulatory roles at the RNA level, the majority—including CAPZA1P3—are believed to function as molecular fossils or have unknown, noncanonical functions. No current evidence supports a role for this pseudogene in the regulation of CAPZA1 or any involvement in disease states or response to therapy[1][3][5]. Key points: - This is not a protein, enzyme, receptor, or canonical drug target. - CAPZA1P3 derives its name from homology to the functional CAPZA1 gene, which encodes a protein involved in actin filament dynamics[2][6], but CAPZA1P3 itself does not encode a functional protein. - There is no evidence for its use as a biomarker, drug target, or its involvement in any known human diseases. Notes on correctness/ambiguity: - While CAPZA1 is an important cytoskeletal protein with therapeutic and biomarker potential[2][6], CAPZA1P3 is a pseudogene and not a molecular target suitable for therapeutic intervention. The only possible caveat is that some pseudogenes have regulatory roles, but no evidence supports such a function for CAPZA1P3 at this time[1][3][5]. - Seeking to associate CAPZA1P3 with functional protein roles or therapeutic targeting is incorrect. - "CAPZA1P3" is properly capitalized and formatted. - There is no evidence for commonly used alternative abbreviations for CAPZA1P3 specifically. Summary for ontology use: CAPZA1P3 is a non-protein-coding pseudogene, with no evidence supporting biological activity, disease association, druggability, or biomarker use in humans. It should not be considered a therapeutic target or functional molecular entity.

Other names

CAPZA1 pseudogene 3CAPZA1P3Capping actin protein of muscle Z-line alpha subunit 1 pseudogene 3Capping actin protein of muscle Z-line α-1 pseudogene 3